ZNF79
gene geneOn this page
Also known as pT7
Summary
ZNF79 (zinc finger protein 79, HGNC:13153) is a protein-coding gene on chromosome 9q33.3, encoding Zinc finger protein 79 (Q15937). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7633 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 88 total
- MANE Select transcript:
NM_007135
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13153 |
| Approved symbol | ZNF79 |
| Name | zinc finger protein 79 |
| Location | 9q33.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | pT7 |
| Ensembl gene | ENSG00000196152 |
| Ensembl biotype | protein_coding |
| OMIM | 194552 |
| Entrez | 7633 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000342483, ENST00000543471, ENST00000612342, ENST00000617266, ENST00000850855, ENST00000850856, ENST00000850857
RefSeq mRNA: 5 — MANE Select: NM_007135
NM_001286696, NM_001286697, NM_001286698, NM_001322260, NM_007135
CCDS: CCDS6871, CCDS69664, CCDS75904
Canonical transcript exons
ENST00000342483 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001036799 | 127435908 | 127436003 |
| ENSE00001036811 | 127435090 | 127435216 |
| ENSE00001460343 | 127444029 | 127445372 |
| ENSE00001460347 | 127424382 | 127424803 |
| ENSE00003520666 | 127428832 | 127428920 |
Expression profiles
Bgee: expression breadth ubiquitous, 199 present calls, max score 84.82.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.1494 / max 91.3627, expressed in 1785 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98607 | 8.1494 | 1785 |
Top tissues by expression
270 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.82 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 84.47 | gold quality |
| tendon | UBERON:0000043 | 77.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.96 | gold quality |
| granulocyte | CL:0000094 | 76.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.24 | gold quality |
| amniotic fluid | UBERON:0000173 | 75.73 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.60 | gold quality |
| medial globus pallidus | UBERON:0002477 | 75.23 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.09 | silver quality |
| muscle of leg | UBERON:0001383 | 74.89 | gold quality |
| secondary oocyte | CL:0000655 | 74.84 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 74.44 | gold quality |
| apex of heart | UBERON:0002098 | 73.83 | gold quality |
| cortical plate | UBERON:0005343 | 73.74 | gold quality |
| muscle organ | UBERON:0001630 | 73.66 | gold quality |
| globus pallidus | UBERON:0001875 | 73.47 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 73.44 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.84 | gold quality |
| ventricular zone | UBERON:0003053 | 72.81 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 72.71 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 72.64 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.64 | gold quality |
| endothelial cell | CL:0000115 | 72.58 | silver quality |
| leukocyte | CL:0000738 | 72.31 | gold quality |
| right adrenal gland | UBERON:0001233 | 72.26 | gold quality |
| adrenal gland | UBERON:0002369 | 72.17 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 72.12 | gold quality |
| monocyte | CL:0000576 | 72.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.84 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| CAT | |
| TICAM2 |
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
8 targeting ZNF79, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
| HSA-MIR-19A-5P | 99.36 | 66.93 | 1675 |
| HSA-MIR-19B-1-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-19B-2-5P | 99.36 | 67.07 | 1669 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-4771 | 97.43 | 67.69 | 596 |
| HSA-MIR-4785 | 88.53 | 62.71 | 63 |
Cross-species orthologs
0 orthologs
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF548 (ENSG00000188785), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 79 — Q15937 (reviewed: Q15937)
Alternative names: ZNFpT7
All UniProt accessions (3): Q15937, A0A087X2B0, F5H032
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (5): NP_001273625, NP_001273626, NP_001273627, NP_001309189, NP_009066* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF00096
UniProt features (19 total): zinc finger region 11, sequence variant 3, sequence conflict 2, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15937-F1 | 68.95 | 0.44 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 57 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, MODULE_48, MODULE_95, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, SMIRNOV_RESPONSE_TO_IR_6HR_UP, WARTERS_RESPONSE_TO_IR_SKIN, ZWANG_DOWN_BY_2ND_EGF_PULSE, MODULE_163, JNK_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BANP_TARGET_GENES, CREB3L4_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| transcription regulatory region nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
526 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF79 | COL5A1 | P20908 | 752 |
| ZNF79 | OR2AG1 | Q9H205 | 669 |
| ZNF79 | ACVRL1 | P37023 | 590 |
| ZNF79 | ENG | P17813 | 587 |
| ZNF79 | BMPR2 | Q13873 | 546 |
| ZNF79 | TFPI | P10646 | 542 |
| ZNF79 | Q6IQ01 | Q6IQ01 | 469 |
| ZNF79 | ADCY10 | Q96PN6 | 401 |
| ZNF79 | ZNF77 | Q15935 | 391 |
| ZNF79 | DEF8 | Q6ZN54 | 335 |
| ZNF79 | OR8G1 | Q15617 | 320 |
| ZNF79 | RNF112 | Q9ULX5 | 300 |
| ZNF79 | HSD17B10 | Q99714 | 294 |
| ZNF79 | C11orf24 | Q96F05 | 292 |
| ZNF79 | OR51F1 | A6NGY5 | 287 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF79 | TRIM27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MDFI | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| TRIM27 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT34 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB24 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGF12 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YJU2B | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF79 | IPO8 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF79 | KRTAP10-8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF79 | KRTAP6-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF79 | KRT34 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FGF12 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZBTB24 | ZNF79 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF79 | YJU2B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF79 (Affinity Capture-RNA), ZNF79 (Affinity Capture-RNA), ZNF79 (Affinity Capture-MS), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), ZNF79 (Two-hybrid), KRTAP6-3 (Two-hybrid), ZNF79 (Negative Genetic)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: B1H2Q6, G5EGB2, O15535, O75290, P17026, P18724, P18741, P18747, P52742, Q15937, Q17895, Q1LZC0, Q3MJ62, Q4R7X8, Q5R4X5, Q6A085, Q7Z3I7, Q8BGV5, Q8TBZ5, Q91VW9, Q969J2, Q9BRR0, Q9ERU2, Q9ERU3, Q9UEG4, Q9Z1D9, Q9Z2K3, A8MQ14, P17097, P21506, Q03936, Q29RZ4, Q3KNS6, Q3V080, Q5RBX0, Q5RBY9, Q5T619, Q6DD87, Q6J6I6, Q6PG37
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
88 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1295 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:127424671:G:GT | donor_gain | 1.0000 |
| 9:127428830:A:AG | acceptor_gain | 1.0000 |
| 9:127428831:G:GA | acceptor_gain | 1.0000 |
| 9:127428831:GTA:G | acceptor_gain | 1.0000 |
| 9:127428831:GTACT:G | acceptor_gain | 1.0000 |
| 9:127435088:A:AG | acceptor_gain | 1.0000 |
| 9:127435088:AG:A | acceptor_gain | 1.0000 |
| 9:127435088:AGG:A | acceptor_gain | 1.0000 |
| 9:127435089:G:A | acceptor_loss | 1.0000 |
| 9:127435089:G:GG | acceptor_gain | 1.0000 |
| 9:127435089:GG:G | acceptor_gain | 1.0000 |
| 9:127435089:GGG:G | acceptor_gain | 1.0000 |
| 9:127435191:A:T | donor_gain | 1.0000 |
| 9:127435213:CTAGG:C | donor_loss | 1.0000 |
| 9:127435214:TAGG:T | donor_loss | 1.0000 |
| 9:127435215:AGG:A | donor_loss | 1.0000 |
| 9:127435216:GGTA:G | donor_loss | 1.0000 |
| 9:127435217:G:A | donor_loss | 1.0000 |
| 9:127435218:T:G | donor_loss | 1.0000 |
| 9:127435901:T:A | acceptor_gain | 1.0000 |
| 9:127435905:TAG:T | acceptor_loss | 1.0000 |
| 9:127435905:TAGGA:T | acceptor_gain | 1.0000 |
| 9:127435906:A:AG | acceptor_gain | 1.0000 |
| 9:127435906:A:AT | acceptor_loss | 1.0000 |
| 9:127435906:AG:A | acceptor_gain | 1.0000 |
| 9:127435907:G:GG | acceptor_gain | 1.0000 |
| 9:127435907:GG:G | acceptor_gain | 1.0000 |
| 9:127435907:GGA:G | acceptor_gain | 1.0000 |
| 9:127435907:GGAC:G | acceptor_gain | 1.0000 |
| 9:127436004:G:GC | donor_loss | 1.0000 |
AlphaMissense
3318 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:127444892:T:C | F398L | 0.999 |
| 9:127444894:C:A | F398L | 0.999 |
| 9:127444894:C:G | F398L | 0.999 |
| 9:127444388:T:C | F230L | 0.998 |
| 9:127444390:C:A | F230L | 0.998 |
| 9:127444390:C:G | F230L | 0.998 |
| 9:127444472:T:C | F258L | 0.998 |
| 9:127444474:C:A | F258L | 0.998 |
| 9:127444474:C:G | F258L | 0.998 |
| 9:127444556:T:C | F286L | 0.998 |
| 9:127444558:C:A | F286L | 0.998 |
| 9:127444558:C:G | F286L | 0.998 |
| 9:127444640:T:C | F314L | 0.998 |
| 9:127444642:C:A | F314L | 0.998 |
| 9:127444642:C:G | F314L | 0.998 |
| 9:127444808:T:C | F370L | 0.998 |
| 9:127444810:C:A | F370L | 0.998 |
| 9:127444810:C:G | F370L | 0.998 |
| 9:127444827:T:C | L376P | 0.998 |
| 9:127445060:T:C | F454L | 0.998 |
| 9:127445062:T:A | F454L | 0.998 |
| 9:127445062:T:G | F454L | 0.998 |
| 9:127444506:G:C | R269P | 0.997 |
| 9:127444724:T:C | F342L | 0.997 |
| 9:127444726:C:A | F342L | 0.997 |
| 9:127444726:C:G | F342L | 0.997 |
| 9:127444837:T:A | H379Q | 0.997 |
| 9:127444837:T:G | H379Q | 0.997 |
| 9:127444911:T:C | L404P | 0.997 |
| 9:127444304:T:C | F202L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000103421 (9:127444360 C>G,T), RS1000155790 (9:127444589 A>G), RS1000195555 (9:127426031 A>G), RS1000238705 (9:127438283 A>T), RS1000301393 (9:127431519 G>T), RS1000472875 (9:127424659 G>A), RS1000537730 (9:127443673 G>A,C), RS1000631037 (9:127426341 C>G), RS1000860296 (9:127436786 G>A,C), RS1000923222 (9:127431225 T>C), RS1000963194 (9:127424395 C>T), RS1001158167 (9:127443352 C>T), RS1001234325 (9:127424618 G>A), RS1001292640 (9:127437143 G>A), RS1001361136 (9:127430551 C>G,T)
Disease associations
OMIM: gene MIM:194552 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 6 |
| Aflatoxin B1 | increases expression, affects expression | 3 |
| sodium arsenite | increases expression, affects cotreatment, decreases expression, increases abundance | 2 |
| Formaldehyde | decreases expression, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| tobacco tar | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| ferrous chloride | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| resorcinol | decreases expression | 1 |
| polyhexamethyleneguanidine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Camptothecin | increases expression | 1 |
| Cisplatin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.